Resilience to diabetic retinopathy
Anara Serikbaeva1, Yanliang Li2, Simon Ma3
1Department of Physiology and Biophysics, University of Illinois at Chicago, 1905 W Taylor St, Chicago, IL 60612, USA.
Progress in Retinal and Eye Research
|May 13, 2024
Summary
Diabetic retinopathy (DR) resistance is linked to mitochondrial defenses in the retina during early diabetes (DM). Understanding these protective mechanisms could lead to therapies that delay DR onset.
Area of Science:
- Ophthalmology
- Endocrinology
- Mitochondrial Biology
Background:
- Chronic hyperglycemia in diabetes mellitus (DM) leads to diabetic retinopathy (DR), a leading cause of vision loss.
- Early stages of hyperglycemia cause subtle retinal changes, while prolonged exposure results in overt, detectable damage.
- The mechanisms preventing maximal retinal damage during the initial phase of hyperglycemia are not well understood.
Purpose of the Study:
- To explore the protective mechanisms that confer resistance to diabetic retinopathy (DR) during the early stages of hyperglycemia.
- To investigate the role of mitochondria-based defense systems in maintaining retinal health despite diabetes (DM).
Main Methods:
- This study reviews recent findings on mitochondrial function and defense pathways in the context of diabetic retinopathy.
- Analysis of cellular resilience mechanisms in the retina during early hyperglycemia.
Main Results:
- Diabetes (DM) activates mitochondria-based defense mechanisms, providing a transient resistance phase against retinopathy.
- Deterioration of this mitochondrial resilience leads to progressive retinal damage.
Conclusions:
- Mitochondrial defense plays a crucial role in the transient retinopathy-resistant phase of diabetes (DM).
- Identifying biomarkers and mediators of this protection is key to developing novel, resilience-based therapies for diabetic retinopathy (DR).
- Therapeutic strategies targeting these protective pathways could indefinitely delay the onset and progression of DR.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:27Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
01:28Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
01:22Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59